Regencell Bioscience Holdings annual capital expenditures (capex)
2020
2022
2023
2024
2025
Regencell Bioscience Holdings Capital Expenditures (CapEx) Growth & History (RGC)
Regencell Bioscience Holdings's capital expenditures (capex) was $152,689 for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $152,689 | $147,313 | +2740.20% |
| 2024 | 2024-06-30 | $5,376 | −$22,016 | −80.37% |
| 2023 | 2023-06-30 | $27,392 | −$753,484 | −96.49% |
| 2022 | 2022-06-30 | $780,876 | — | — |
| 2020 | 2020-06-30 | $117,837 | — | — |
Regencell Bioscience Holdings capital expenditures (capex) trends
Over the last five fiscal years, Regencell Bioscience Holdings's capital expenditures (capex) increased from $117,837 to $152,689, a change of $34,852.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗